Evolent Health, Inc.
EVH
$9.19
-$0.80-8.01%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,346.68% | -273.95% | 31.75% | 8.64% | 104.65% |
| Total Depreciation and Amortization | -24.29% | -23.47% | 195.13% | -9.31% | -8.54% |
| Total Amortization of Deferred Charges | -6.46% | 3.62% | -19.62% | -14.70% | -22.25% |
| Total Other Non-Cash Items | 67.02% | 127.29% | -25.88% | -34.08% | -27.96% |
| Change in Net Operating Assets | -128.54% | 39.90% | -175.93% | -128.31% | -24.34% |
| Cash from Operations | -241.64% | -7.01% | -129.35% | -69.15% | 3,174.77% |
| Capital Expenditure | -416.96% | -94.49% | 142.48% | -154.51% | -70.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.68% | -- | -- | -3,536.62% | -14,507.69% |
| Cash from Investing | -347.02% | -34.54% | -229.31% | -221.06% | -62.09% |
| Total Debt Issued | -- | -- | -85.04% | -- | -- |
| Total Debt Repaid | -- | -11,714.74% | 100.13% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -48.27% | -98.01% |
| Repurchase of Common Stock | 92.31% | 67.96% | 67.16% | 56.83% | -163.77% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 8.80% | 9.87% | 6.90% | -0.75% | -3.75% |
| Other Financing Activities | 95.64% | -222.84% | 176.28% | 78.07% | -483.66% |
| Cash from Financing | 91.36% | 624.73% | 214.93% | 75.89% | -543.12% |
| Foreign Exchange rate Adjustments | -245.83% | 160.53% | -655.56% | 71.82% | -2,300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.55% | 891.41% | 4,965.03% | -159.76% | -711.23% |